Search research articles
Contact Us
Filters
Showing results (871-880 of 973) with videos related to
Page
of 98
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 22, 2020
Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma
Dongguang Wei, Mohamed M Zaid, Matthew H Katz, et al.
Oncotargets and Therapy
|
March 2, 2016
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
Ahmed O Kaseb, Jeffrey S Morris, Michiko Iwasaki, et al.
Klinische Padiatrie
|
May 3, 2016
Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents - Recommendations of the GPOH-NPC Study Group
U Kontny, S Franzen, U Behrends, et al.
Annals of Surgical Oncology
|
October 17, 2018
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Pat Gulhati, Laura Prakash, Matthew H G Katz, et al.
Gastroenterology
|
April 4, 2015
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma
Manal M Hassan, Reham Abdel-Wahab, Ahmed Kaseb, et al.
Annals of Surgical Oncology
|
February 18, 2010
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation
Matthew H G Katz, Gauri R Varadhachary, Jason B Fleming, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2010
A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivity
Markus A Schirmer, Jürgen Brockmöller, Margret Rave-Fränk, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2002
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Christopher H Crane, James L Abbruzzese, Douglas B Evans, et al.
Oncotarget
|
November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience
Jennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2008
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases
Dan G Blazer, Yoji Kishi, Dipen M Maru, et al.
Page
of 98
Search research articles
Search
Showing results (871-880 of 973) with videos related to
Sort By:
Page
of 98
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 22, 2020
Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma
Dongguang Wei, Mohamed M Zaid, Matthew H Katz, et al.
Oncotargets and Therapy
|
March 2, 2016
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
Ahmed O Kaseb, Jeffrey S Morris, Michiko Iwasaki, et al.
Klinische Padiatrie
|
May 3, 2016
Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents - Recommendations of the GPOH-NPC Study Group
U Kontny, S Franzen, U Behrends, et al.
Annals of Surgical Oncology
|
October 17, 2018
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Pat Gulhati, Laura Prakash, Matthew H G Katz, et al.
Gastroenterology
|
April 4, 2015
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma
Manal M Hassan, Reham Abdel-Wahab, Ahmed Kaseb, et al.
Annals of Surgical Oncology
|
February 18, 2010
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation
Matthew H G Katz, Gauri R Varadhachary, Jason B Fleming, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2010
A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivity
Markus A Schirmer, Jürgen Brockmöller, Margret Rave-Fränk, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2002
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Christopher H Crane, James L Abbruzzese, Douglas B Evans, et al.
Oncotarget
|
November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience
Jennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2008
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases
Dan G Blazer, Yoji Kishi, Dipen M Maru, et al.
Page
of 98